Autism Spectrum Disorder

Zhittya Genesis Medicine is exploring the role of vascular dysfunction as a contributing factor to autism, a neurodevelopmental disorder affecting millions globally. Recent research highlights that individuals with autism often exhibit issues with angiogenesis—the growth of new blood vessels—critical for maintaining healthy brain function and nutrient delivery. This vascular irregularity impacts cerebral blood flow and has been linked to autism-related behaviors, such as communication challenges and sensory processing difficulties. Zhittya's innovative approach focuses on using their Fibroblast Growth Factor 1 (FGF-1) therapy to stimulate angiogenesis and restore proper vascular function, with the potential to address these underlying issues in autism.